Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy

Strahlentherapie und Onkologie

Volumn 188, Issue 2, 2012, Pages 160-167

  Fotina, I ^a   Lutgendorf Caucig C ^a   Stock, M ^a   Potter R ^a   Georg, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Conformity index; Inter observer variability; Radiotherapy; Similarity metrics; Target volume delineation

Indexed keywords

ARTICLE; CALCULATION; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HUMAN; LUNG CANCER; OBSERVER VARIATION; PARAMETERS; PROSTATE CANCER; FEMALE; IMAGE GUIDED RADIOTHERAPY; LUNG TUMOR; MALE; METHODOLOGY; PROSTATE TUMOR; RADIOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

FEMALE; HUMANS; LUNG NEOPLASMS; MALE; OBSERVER VARIATION; PROSTATIC NEOPLASMS; RADIOTHERAPY, IMAGE-GUIDED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858032106     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-011-0027-6     Document Type: Article

References (53)

1. Allozi R, Li XA, White J et al (2010) Tools for consensus analysis of experts' contours for radiotherapy structure definitions. Radiother Oncol 97:572-578
2. Altorjai G, Fotina I, Lütgendorf-Caucig C et al (2011) Cone-beam ct-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability. Int J Radiat Oncol Biol Phys [Epub ahead of print]
3. Berthelet E, Liu MC, Agranovich A et al (2002) Computed tomography determination of prostate volume and maximum dimensions: a study of interobserver variability. Radiother Oncol 63:37-40
4. Breen SL, Publicover J, De Silva S et al (2007) Intraobserver and inter-observer variability in GTV delineation on FDG-PET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys 68:763-770
5. Castro Pena P, Kirova YM, Campana F et al (2009) Anatomical, clinical and radiological delineation of target volumes in breast cancer radiotherapy planning: individual variability, questions and answers. Br J Radiol 82:595-599
6. Dimopoulos JC, De Vos V, Berger D et al (2009) Inter- observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 91:166-172
7. Eliasziw M, Young SL, Woodbury MG et al (1994) Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example. Phys Ther 74:777-788
8. Fuller CD, Nijkamp J, Duppen JC et al (2011) Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting. Int J Radiat Oncol Biol Phys 79:481-489
9. Genovesi D, Cèfaro GA, Vinciguerra A et al (2011) Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience. Strahlenther Onkol 187:357-366
10. Giezen M, Kouwenhoven E, Scholten AN et al (2011) Magnetic resonance imaging- versus computed tomography-based target volume delineation of the glandular breast tissue in breast-conserving therapy: an exploratory study. Int J Radiat Oncol Biol Phys 81:804-811
11. Giraud P, Elles S, Helfre S et al (2002) Conformal radiotherapy for lung cancer: different delineation of the gross tumour volume (GTV) by radiologists and radiation oncologists. Radiother Oncol 62:27-36
12. Goldner G, Dimopoulos J, Kirisits C, Pötter R (2009) Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. Strahlenther Onkol 185:438-445
13. Grabarz D, Panzarella T, Bezjak A et al (2011) Quantifying interobserver variation in target definition in Palliative Radiotherapy. Int J Radiat Oncol Biol Phys 80:1498-1504
14. Guckenberger M, Ok S, Polat B et al (2010) Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 186:535-43 (Erratum: Strahlenther Onkol 2010;186:705)
15. International Commission on Radiation Units and Measurements. ICRU Report 62 (1999) Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50). ICRU, Bethesda, MD, USA
16. Hentschel B, Oehler W, Strauss D et al (2011) Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187:183-190
17. Jansen EP, Nijkamp J, Gubanski M et al (2010) Interobserver variation of clinical target volume delineation in gastric cancer. Int J Radiat Oncol Biol Phys 77:1166-1170
18. Kouwenhoven E, Giezen M, Struikmans H (2009) Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 54:2863-2873
19. Krengli M, Cannillo B, Turri L et al (2010) Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging. Technol Cancer Res Treat 9:393-398
20. Lawton CA, Michalski J, El-Naqa I et al (2009) Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 74:377-382
21. Leunens G, Menten J, Weltens C et al (1993) Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours. Radiother Oncol 29:169-175
22. Li XA, Tai A, Arthur DW, Buchholz TA et al (2009) Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi- Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys 73:944-951
23. Logue JP, Sharrock CL, Cowan RA et al (1998) Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 41:929-9231
24. Louie AV, Rodrigues G, Olsthoorn J et al (2010) Inter- observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era. Radiother Oncol 95:166-171
25. Lütgendorf-Caucig C, Fotina I, Stock M et al (2011) Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. Radiother Oncol 98:154-161
26. Metwally H, Courbon F, David I et al (2011) Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition. Int J Radiat Oncol Biol Phys 80:793-799
27. Mitchell JR, Karlik SJ, Lee DH et al (1996) The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Med Phys 23:85-97
28. Njeh CF (2008) Tumor delineation: The weakest link in the search for accuracy in radiotherapy. J Med Phys 33:136-140
29. Petersen RP, Truong PT, Kader HA et al (2007) Target volume delineation for partial breast radiotherapy planning: Clinical characteristics associated with low interobserver concordance. Int J Radiat Oncol Biol Phys 69:41-48
30. Pinkawa M, Holy R, Piroth MD et al (2010) Intensity- modulated radiotherapy for prostate cancer implementing molecular imaging with 18 F-choline PET-CT to define a simultaneous integrated boost. Strahlenther Onkol 186:600-606
31. Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479-484
32. Rasch C, Barillot I, Remeijer P et al (1999) Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43:57-66
33. Rasch C, Steenbakkers R, Herk M van (2005) Target definition in prostate, head, and neck. Semin Radiat Oncol 15:136-145
34. Rasch CR, Steenbakkers RJ, Fitton I et al (2010) Decreased 3D observer variation with matched CTMRI, for target delineation in nasopharynx cancer. Radiat Oncol 5:21
35. Senan S, Koste J de, Samson M et al (1999) Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol 53:247-255
36. Smith WL, Lewis C, Bauman G et al (2007) Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 67:1238-1247
37. Song W, Chiu B, Bauman G et al (2006) Prostate contouring uncertainty in megavoltage computed tomography images acquired with a helical tomotherapy unit during image-guided radiation therapy. Int J Radiat Oncol Biol Phys 65:595-607
38. Steenbakkers RJ, Duppen JC, Fitton I et al (2006) Reduction of observer variation using matched CTPET for lung cancer delineation: a three-dimensional analysis. Int J Radiat Oncol Biol Phys 64:435-434
39. Stock M, Dörr W, Stromberger C et al (2010) Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlenther Onkol 186:665-671
40. Stroom JC, Heijmen BJ (2002) Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol 64:75-83
41. Struikmans H, Wárlám-Rodenhuis C, Stam T et al (2005) Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol 76:293-299
42. Tong S, Cardinal HN, McLoughlin RF et al (1998) Intra-and interobserver variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 24:673-681
43. Tyng CJ, Chojniak R, Pinto PN et al (2009) Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists. Radiat Oncol 4:28
44. Usmani N, Sloboda R, Kamal W et al (2011) Can images obtained with high field strength magnetic resonance imaging reduce contouring variability of the prostate? Int J Radiat Oncol Biol Phys 80:728-734
45. Baardwijk A van, Bosmans G, Boersma et al (2007) PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 68:771-778
46. Mourik AM van, Elkhuizen PH, Minkema D et al (2010) Multiinstitutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines. Radiother Oncol 94:286-291
47. Villeirs GM, Van Vaerenbergh K, Vakaet L et al (2005) Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 181:424-430
48. Vorwerk H, Beckmann G, Bremer M et al (2009) The delineation of target volumes for radiotherapy of lung cancer patients. Radiother Oncol 91:455-460
49. Weiss E, Hess CF (2003) The impact of gross tumor volume (GTV) and clinical target volume (CTV) definition on the total accuracy in radiotherapy theoretical aspects and practical experiences. Strahlenther Onkol 179:21-30
50. Weiss E, Richter S, Krauss T et al (2003) Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of the clinical target volume. A comparison between gynaecologic and radiation oncologists. Radiother Oncol 67:87-95
51. Weiss E, Wu J, Sleeman W et al (2010) Clinical evaluation of soft tissue organ boundary visualization on cone-beam computed tomographic imaging. Int J Radiat Oncol Biol Phys 78:929-936
52. Weltens C, Menten J, Feron M et al (2001) Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging. Radiother Oncol 60:49-59
53. White EA, Brock KK, Jaffray DA et al (2009) Interobserver variability of prostate delineation on cone beam computerised tomography images. Clin Oncol 21:32-38